Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
Контент предоставлен Proactive Investors. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Proactive Investors или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Player FM - приложение для подкастов
Работайте офлайн с приложением Player FM !
Работайте офлайн с приложением Player FM !
Graft Polymer UK CEO discusses strong progress in Awakn Life Sciences collaboration
MP3•Главная эпизода
Manage episode 436624057 series 2891889
Контент предоставлен Proactive Investors. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Proactive Investors или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Graft Polymer (UK) PLC CEO Anthony Tennyson takes Proactive's Stephen Gunnion through the progress the company has made in its commercial collaboration with Awakn Life Sciences. Tennyson explained the collaboration is aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD). He noted that Awakn has successfully identified two aminoindane chemical series as lead candidates, marking a crucial step forward in drug development. These compounds show promise in improving treatment options for conditions like PTSD, which affects millions globally. Additionally, synthesis pathways for these compounds have been defined, ensuring scalable production as the project advances towards more rigorous pharmacological testing. To further bolster the collaboration, Charnwood Discovery, a UK-based leader in drug discovery services, has been selected as the synthesis partner. Also, a new provisional patent was filed on August 27 with the US Patent and Trademark Office. For more insights into Graft Polymer's growth strategy and technological innovations, be sure to watch the full interview. Don’t forget to give the video a like, subscribe to the channel, and enable notifications for future content. #GraftPolymer #PolymerTechnology #Innovation #AnthonyTennyson #MaterialsScience #TechAdvancements #R&D #Sustainability #FutureOfMaterials #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
610 эпизодов
MP3•Главная эпизода
Manage episode 436624057 series 2891889
Контент предоставлен Proactive Investors. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Proactive Investors или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Graft Polymer (UK) PLC CEO Anthony Tennyson takes Proactive's Stephen Gunnion through the progress the company has made in its commercial collaboration with Awakn Life Sciences. Tennyson explained the collaboration is aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD). He noted that Awakn has successfully identified two aminoindane chemical series as lead candidates, marking a crucial step forward in drug development. These compounds show promise in improving treatment options for conditions like PTSD, which affects millions globally. Additionally, synthesis pathways for these compounds have been defined, ensuring scalable production as the project advances towards more rigorous pharmacological testing. To further bolster the collaboration, Charnwood Discovery, a UK-based leader in drug discovery services, has been selected as the synthesis partner. Also, a new provisional patent was filed on August 27 with the US Patent and Trademark Office. For more insights into Graft Polymer's growth strategy and technological innovations, be sure to watch the full interview. Don’t forget to give the video a like, subscribe to the channel, and enable notifications for future content. #GraftPolymer #PolymerTechnology #Innovation #AnthonyTennyson #MaterialsScience #TechAdvancements #R&D #Sustainability #FutureOfMaterials #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
610 эпизодов
Все серии
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.